Colonai
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2018Stage
Seed | AliveTotal Raised
$30KLast Raised
$30K | 2 yrs agoAbout Colonai
Colonai uses artificial intelligence to help gastroenterologists, physicians who specialize in diseases of the digestive system, efficiently screen, detect and treat tumors during colonoscopy. The team has developed two products that can be integrated into current workflow: i) PolypSense, highlights suspicious areas in the colon that may have a tumor in the field of view and covers the physician’s blind spots, and ii) PolypSect, helps doctors define the margins between tumors and healthy tissue, to aid in achieving a complete resection.
Colonai Headquarters Location
3143 Broadway
New York, New York, 10027,
United States
Expert Collections containing Colonai
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Colonai is included in 7 Expert Collections, including Digital Health.
Digital Health
21,937 items
Startups recreating how healthcare is delivered
Artificial Intelligence
9,093 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
8,454 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Health IT
10,579 items
This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.
When was Colonai founded?
Colonai was founded in 2018.
Where is Colonai's headquarters?
Colonai's headquarters is located at 3143 Broadway, New York.
What is Colonai's latest funding round?
Colonai's latest funding round is Seed.
How much did Colonai raise?
Colonai raised a total of $30K.
Who are the investors of Colonai?
Investors of Colonai include Health Wildcatters.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.